DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0004779 | Basal Cell Nevus Syndrome | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0751956 | Acute Cerebrovascular Accidents | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C1332977 | Childhood Leukemia | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0017636 | Glioblastoma | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0023487 | Acute Promyelocytic Leukemia | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0023473 | Myeloid Leukemia, Chronic | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0279606 | Childhood Hepatocellular Carcinoma | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0409974 | Lupus Erythematosus | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0008354 | Cholera | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0268292 | Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0042769 | Virus Diseases | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0027086 | Myoma | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0022658 | Kidney Diseases | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C2930619 | Sex Differentiation Disorders | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0040136 | Thyroid Neoplasm | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0162533 | Porphyrias, Hepatic | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0036391 | Schwartz-Jampel Syndrome | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0027765 | nervous system disorder | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0027609 | Neonatal Abstinence Syndrome | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0003873 | Rheumatoid Arthritis | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0020503 | Hyperparathyroidism, Secondary | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C1260386 | Glucocorticoid-remediable aldosteronism | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0037286 | Skin Neoplasms | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0595989 | Carcinoma of larynx | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024